Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N03AX12	PMS-GABAPENTIN	G	Gabapentin - 300mg	300mg	Capsule	869,466 L.L
G03GA06	PUREGON	BioHuman	Follitropin beta - 300IU/0.36ml	300IU/0.36ml	Injectable solution	12,929,605 L.L
G03GA06	PUREGON	BioHuman	Follitropin beta - 300IU/0.36ml	300IU/0.36ml	Injectable solution	12,929,605 L.L
C10AA08	PIVAL	G	Pitavastatin - 2mg	2mg	Tablet	802,466 L.L
N05AX08	PMS-RISPERIDONE	G	Risperidone - 2mg	2mg	Tablet	931,283 L.L
A07EC02	PENTASA XTEND	B	Mesalazine - 2g	2g	Granules for suspension	8,550,789 L.L
L04AX05	PULMOFIB 267	G	Pirfenidone - 267mg	267mg	Tablet, film coated	20,481,044 L.L
R06AD02	PROMETAL	G	Promethazine - 25mg	25mg	Tablet	194,537 L.L
R06AD02	PROMETAL	G	Promethazine - 25mg	25mg	Tablet	8,003,607 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 25mg	25mg	Capsule	4,121,565 L.L
N05AH04	PMS-QUETIAPINE	G	Quetiapine fumarate - 25mg	25mg	Tablet	814,369 L.L
G03BB01	PROVIRON	B	Mesterolone - 25mg	25mg	Tablet	391,058 L.L
G03DA04	PROLUTEX	B	Progesterone - 25mg	25mg	Injectable solution	5,570,227 L.L
N02BF02	PLENICA	G	Pregabalin - 25mg	25mg	Capsule	697,454 L.L
N02BF02	PMS-PREGABALIN	G	Pregabalin - 25mg	25mg	Capsule	770,022 L.L
N02BF02	PREGAFORTE 25	G	Pregabalin - 25mg	25mg	Capsule	700,078 L.L
G03DA03	PROLUTON DEPOT	B	Hydroxyprogesterone caproate - 250mg/ml	250mg/ml	Injectable solution	270,112 L.L
N03AB02	PHENTOLEP INJECTION	G	Phenytoin (sodium) - 250mg/5ml	250mg/5ml	Injectable solution	1,447,318 L.L
M01AE02	PROXEN 250	B	Naproxen - 250mg	250mg	Tablet, film coated	542,912 L.L
N02BE01	PARA-DENK 250 SUPPOS.	G	Paracetamol - 250mg	250mg	Suppository	190,826 L.L
N02BE01	PARA-DENK 250 SUPPOS.	G	Paracetamol - 250mg	250mg	Suppository	190,826 L.L
A04AA05	PALONAN	G	Palonosetron HCl - 250mcg/5ml	250mcg/5ml	Injectable solution	2,194,495 L.L
N02BE01	PAROL CHILDREN	G	Paracetamol - 240mg/5ml	240mg/5ml	Elixir	314,843 L.L
J05AX18	PREVYMIS	B	Letermovir - 240mg/12ml	240mg/12ml	Injectable concentrate for solution	23,599,640 L.L
J05AX18	PREVYMIS	B	Letermovir - 240mg	240mg	Tablet, film coated	460,943,945 L.L
S01EC03	PROGLAU	G	Dorzolamide HCl - 20mg/ml	20mg/ml	Drops solution	517,379 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 20mg	20mg	Tablet, gastroresistant	294,302 L.L
N06AB03	PMS-FLUOXETINE	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	592,635 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	440,780 L.L
N06AB03	PROXETIN	G	Fluoxetine (HCl) - 20mg	20mg	Capsule	374,996 L.L

...